Movano SG&A Expenses 2020-2024 | MOVE

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Movano sg&a expenses from 2020 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Movano sg&a expenses from 2020 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$46.1B
Tempus AI (TEM)	$13.3B
Doximity (DOCS)	$12B
Hims & Hers Health (HIMS)	$9.9B
IRhythm Technologies (IRTC)	$5.4B
Hinge Health (HNGE)	$4.4B
Inspire Medical Systems (INSP)	$2.7B
Privia Health (PRVA)	$2.6B
Heartflow (HTFL)	$2.3B
Phreesia (PHR)	$1.7B
Enovis (ENOV)	$1.7B
10x Genomics (TXG)	$1.6B
Omnicell (OMCL)	$1.5B
Schrodinger (SDGR)	$1.4B
Azenta (AZTA)	$1.4B
Clover Health Investments (CLOV)	$1.3B
Claritev (CTEV)	$1.1B
Evolent Health (EVH)	$1B
Fulgent Genetics (FLGT)	$655M
Zepp Health (ZEPP)	$580M
Veradigm (MDRX)	$525M
Standard BioTools (LAB)	$458M
Talkspace (TALK)	$456M
Butterfly Network (BFLY)	$350M
Carlsmed (CARL)	$342M
TruBridge (TBRG)	$296M
Outset Medical (OM)	$243M
SOPHiA GENETICS SA (SOPH)	$232M
Nyxoah SA (NYXH)	$216M
Health Catalyst (HCAT)	$215M